Working to improve global cancer care access in low middle-income countries

Prostate cancer screening: A novel risk prediction tool with standard biopsies vs PSA with MRI-targeted biopsies

ASCO Direct Highlights 2022: prostate cancer highlights

Locally and advanced immunotherapy developments and new agents in lung cancer

Latest updates in hormone receptor positive HER2 negative breast cancer

War in Ukraine: The International Brain Tumour Alliance's response to aiding refugees during the crisis

Treatment with high-dose multi-agent chemotherapy for high-risk lymphoma is effective but with significant toxicity

Comment: Addition of ixazomib to pomalidomide and dexamethasone improves survival for multiple myeloma patients

EHA update: Lenalidomide, bortezomib, and dexamethasone ASCT to progress for NDMM

Glofitamab induces durable complete remissions in patients with relapsed large B-cell lymphoma

Time-limited venetoclax-obinutuzumab +/- ibrutnib surpasses chemoimmunotherapy in frontline chronic lymphocytic leukaemia

Quizartinib advances overall survival in acute myeloid leukaemia patients